Cryo-Cell International Q1 EPS $0.07 Beats $(0.02) Estimate, Sales $7.85M Miss $7.93M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cryo-Cell International (NASDAQ:CCEL) reported Q1 earnings of $0.07 per share, surpassing the $(0.02) estimate, a 450% beat, but saw a 22.22% decrease from last year's $0.09. Sales reached $7.85M, missing the $7.93M estimate by 1.01%, yet marking a 0.38% increase from the previous year.
April 15, 2024 | 9:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cryo-Cell International reported a significant earnings beat but a slight miss on sales forecasts for Q1, with a year-over-year decrease in earnings but a slight increase in sales.
The significant beat on earnings per share (EPS) estimates is likely to positively impact investor sentiment towards CCEL in the short term, despite the slight miss on sales estimates and the year-over-year decrease in earnings. The increase in sales, even if marginal, indicates some level of growth, which could further support the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100